(Q39493708)

12 September 2017

1 reference

title

Pharmacokinetic interactions between digoxin and other drugs (English)

1 reference

12 September 2017

0 references

1 reference

F I Marcus

1

1 reference

PubMed ID

2985676

12 September 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

Journal of the American College of Cardiology

12 September 2017

1 reference

12 September 2017

5

1 reference

12 September 2017

82A-90A

1 reference

12 September 2017

5 Suppl A

1 reference

A METHOD FOR MEASURING PLASMA LEVELS OF DIGITALIS GLYCOSIDES

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The measurement of digitoxin in human serum by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of quinidine on plasma concentrations of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Drug interactions with digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Decreased bioavailability of digoxin due to hypocholesterolemic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Decreased bioavailability of digoxin due to antacids and kaolin-pectin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Influence of antacids on plasma concentration of digoxin in man (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The uptake of digoxin and digitoxin by some antacids

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Influence of kaolin--pectin suspension on digoxin bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Lack of effect of bran on digoxin absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of sulfasalazine on digoxin bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Urinary excretion of reduced metabolites of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin metabolism in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effects of cytostatic drugs on plasma level and renal excretion of β-acetyldigoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effects of quinidine on serum digoxin concentration: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interaction of quinidine and digoxin in humans (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of quinidine on digoxin bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin bioavailability during quinidine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-quinidine interaction Pharmacokinetic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Renal function and digoxin clearance during quinidine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Quinidine and the non-renal elimination of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-quinidine interaction in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Quinidine-digoxin interaction: Time course and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

A previously unrecognized drug interaction between quinidine and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interaction between quinidine and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Fatal Digoxin‐Quinidine Interaction in an Elderly Woman

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Reduction of digoxin-induced inotropism during quinidine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Further insights into digoxin-quinidine interaction: lack of correlation between serum digoxin concentration and inotropic state of the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Reduction of digoxin effect during the digoxin-quinidine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Cardiac effects of treatment with quinidine and digoxin, alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of quinine on digoxin kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-hydroxychloroquine interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Amiodarone increases plasma digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Amiodarone-digoxin interaction. Clinical and experimental observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Pharmacokinetic evaluation of the digoxin-amiodarone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin toxicity associated with amiodarone therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

On the interaction between digoxin and disopyramide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of oral disopyramide on serum digoxin levels. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interaction between mexiletine and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interaction of flecainide with digoxin and propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Verapamil-digoxin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The influence of verapamil on serum digoxin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-verapamil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Influence of verapamil on the inotropism and pharmacokinetics of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Verapamil-digoxin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The diltiazem-digoxin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The effect of nifedipine on serum digoxin concentrations in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of nifedipine on digoxin kinetics in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of nifedipine on serum digoxin concentration and renal digoxin clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interaction between digoxin and calcium antagonists and antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of furosemide on the renal excretion of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin kinetics during furosemide administration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Renal clearance of digoxin in man after sodium loading or furosemide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Effect of chronic potassium depletion on digitalis-induced inotropy and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Suppression of renal excretion of digoxin in hypokalemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Interactions between digoxin and potassium-sparing diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Amiloride-induced changes in digoxin dynamics and kinetics: abolition of digoxin-induced inotropism with amiloride

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Spironolactone-induced changes in digoxin kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The interaction of spironolactone and digoxin: a review and evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-quinidine-spironolactone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Kinetics of the digoxin-aspirin combination

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The effect of ibuprofen on serum digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Digoxin-rifampin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Rifampin and digoxin: possible drug interaction in a dialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Rifampin drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

The influence of rifampin on quinidine and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Non-interaction of cimetidine with digoxin absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2885%2980466-6

7 January 2021

10.1016/S0735-1097(85)80466-6

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

2985676